Robert J. Mears - Dec 1, 2022 Form 4 Insider Report for Atomera Inc (ATOM)

Role
Chief Technology Officer
Signature
/s/ Mindi Zimmer as Attorney in Fact for Robert Mears
Stock symbol
ATOM
Transactions as of
Dec 1, 2022
Transactions value $
-$81,219
Form type
4
Date filed
12/2/2022, 05:01 PM
Previous filing
Sep 2, 2022
Next filing
Feb 28, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ATOM Common Stock Options Exercise $39K +10K +8.85% $3.90 123K Dec 1, 2022 Direct F1
transaction ATOM Common Stock Sale -$82K -10K -8.13% $8.20 113K Dec 1, 2022 Direct F2
transaction ATOM Common Stock Sale -$2.08K -248 -0.22% $8.37 113K Dec 1, 2022 Direct F3
transaction ATOM Common Stock Sale -$996 -119 -0.11% $8.37 113K Dec 1, 2022 Direct F3
transaction ATOM Common Stock Sale -$7.9K -944 -0.84% $8.37 112K Dec 1, 2022 Direct F3
transaction ATOM Common Stock Sale -$4.85K -579 -0.52% $8.37 111K Dec 1, 2022 Direct F3
transaction ATOM Common Stock Sale -$22.4K -2.8K -2.52% $8.00 108K Dec 2, 2022 Direct F2
holding ATOM Common Stock 2.67K Dec 1, 2022 by Spouse

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ATOM Employee Stock Option (right to buy) Options Exercise $0 -10K -14.94% $0.00 56.9K Dec 1, 2022 Common Stock 10K $3.90 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option exercise reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person and exercised from apreviously reported total.
F2 The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.
F3 Represents the number of shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock grants that were previously reported. This sale is to satisfy mandatory non-discretionary tax withholding obligations by a "sell to cover" transaction.